Sakar Healthcare Q4 FY26 Net Profit Up 91% YoY

Sakar Healthcare reported Q4 FY26 consolidated revenue of INR71.10 crores, up 42% YoY, and net profit of INR11.02 crores, up 91% YoY.
The company is transitioning into a focused export-led oncology player, with the division contributing 38% of total revenue in FY26.
Management provided an aspirational revenue target of INR380 crores for FY27, expecting 40% growth driven by oncology scale-up.
The EU GMP-approved oncology facility has a long-term revenue potential of INR800-1000 crores and is currently operating below 30% capacity.